Skip to content
value.today

Vedanta Biosciences, Inc.

Total raised
$240 M
4 rounds on record
Latest round
$119 M
Mar 2023
First round on record
Dec 2018
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Vedanta Biosciences, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2023$119 MNo. 4$50 to $250 million

Vedanta Biosciences, Inc.: Raise no. 4, Mar 2023

Investors in this round

25 investors had bought by the notice of Aug 5, 2024: 25 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$119 M of $119 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
$400,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bernat Olle · Executive Officer, Director
  • Daniel Couto · Executive Officer
  • Jeffrey Silber · Executive Officer
  • Mark Mullikin · Executive Officer
  • Bennett Shapiro · Director
  • Charles Sherwood · Director
  • Curt LaBelle · Director
  • John LaMattina · Director
  • Martin Heidecker · Director
  • Neil Tiwari · Director
  • Susan Dillon · Director
  • Troy Ignelzi · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • FJS Consultants Limited · Sheung Wan, Hong KongSold in no state named, and outside the US

Signed by Mark Mullikin, Treasurer. Newest notice filed Aug 5, 2024 (1 amendment). Read the notice at the SEC.

debt, optionsSEC
Jul 2021$68 MNo. 3$50 to $250 million

Vedanta Biosciences, Inc.: Raise no. 3, Jul 2021

Investors in this round

18 investors had bought by the notice of Aug 13, 2021: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$68 M of $75 M offered; $7 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$400,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bernat Olle · Executive Officer, Director
  • Daniel L Couto · Executive Officer
  • Jeffrey L Silber · Executive Officer
  • Mark L Mullikin · Executive Officer
  • Bennett M Shapiro · Director
  • Bharatt Chowrira · Director
  • Christopher M Viehbacher · Director
  • John L LaMattina · Director
  • Susan Dillon · Director
  • Troy Ignelzi · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • FJS Consultants Limited · Sheung Wan, Hong KongSold in no state named, and outside the US

Remarks in the notice

  • On the amounts: “Includes an aggregate of $25,797,260.27 in principal and interest in connection with the conversion of a promissory note.”

Signed by Mark Mullikin, Treasurer. Newest notice filed Aug 13, 2021. Read the notice at the SEC.

equitySEC
Sep 2019$8 MNo. 2$2 to $10 million

Vedanta Biosciences, Inc.: Raise no. 2, Sep 2019

Investors in this round

4 investors had bought by the notice of Sep 19, 2019: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $17 M offered; $9 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$160,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bernat Olle · Executive Officer, Director
  • Bennett M. Shapiro · Director
  • Bharatt M. Chowrira · Director
  • Christopher Viehbacher · Director
  • John L. LaMattina · Director
  • Susan M. Dillon · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • China eCapital Partners, LLC (CRD 150251) · Los Angeles, CaliforniaSold in no state named, and outside the US

Signed by Bernat Olle, Chief Executive Officer. Newest notice filed Sep 19, 2019. Read the notice at the SEC.

equitySEC
Dec 2018$45 MNo. 1$10 to $50 million

Vedanta Biosciences, Inc.: Raise no. 1, Dec 2018

Investors in this round

13 investors had bought by the notice of May 8, 2019: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$45 M of $50 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bernat Olle · Executive Officer, Director
  • Bennett M. Shapiro · Director
  • Bharatt M. Chowrira · Director
  • Christopher Viehbacher · Director
  • John L. LaMattina · Director
  • Susan M. Dillon · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Bernat Olle, Chief Executive Officer. Newest notice filed May 8, 2019 (2 amendments). Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Vedanta Biosciences, Inc. chose not to state its revenue in its newest notice of a funding round (Aug 2024).

    SEC Form D · Aug 2024

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Aug 2024

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Vedanta Biosciences, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Vedanta Biosciences, Inc.
NameRoleNamed in
Bernat OlleExecutive officerAug 2024
Daniel CoutoExecutive officerAug 2024
Jeffrey SilberExecutive officerAug 2024
Mark MullikinExecutive officerAug 2024
Daniel L CoutoExecutive officerAug 2021
Jeffrey L SilberExecutive officerAug 2021
Mark L MullikinExecutive officerAug 2021
Bennett ShapiroDirectorAug 2024
Bernat OlleDirectorAug 2024
Charles SherwoodDirectorAug 2024
Curt LaBelleDirectorAug 2024
John LaMattinaDirectorAug 2024
Martin HeideckerDirectorAug 2024
Neil TiwariDirectorAug 2024
Susan DillonDirectorAug 2024
Troy IgnelziDirectorAug 2024
Bennett M ShapiroDirectorAug 2021
Bharatt ChowriraDirectorAug 2021
Christopher M ViehbacherDirectorAug 2021
John L LaMattinaDirectorAug 2021
Bennett M. ShapiroDirectorSep 2019
Bharatt M. ChowriraDirectorSep 2019
Christopher ViehbacherDirectorSep 2019
John L. LaMattinaDirectorSep 2019
Susan M. DillonDirectorSep 2019